Stocktoria
Cabaletta Bio, Inc. CABA
Nasdaq · XNAS · stock · Biological Products, (No Diagnostic Substances) · website · IPO 2019-10-25
Cabaletta Bio, Inc. institutional holders (13F)
| Investor | Shares | Value |
|---|---|---|
| BlackRock Finance, Inc. | 4,756,219 | $35.6M |
| MILLENNIUM MANAGEMENT LLC | 5,903,281 | $15.9M |
| TWO SIGMA INVESTMENTS, LP | 2,497,917 | $6.7M |
| RENAISSANCE TECHNOLOGIES LLC | 2,036,663 | $5.5M |
| CITADEL ADVISORS LLC | 560,800 | $1.5M |
| Point72 Asset Management, L.P. | 246,615 | $663,394 |
| D. E. Shaw & Co., Inc. | 189,412 | $509,518 |
Source: SEC EDGAR filings · CIK 0001759138 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.